Gastro retentive floating drug delivery system of model drug using central composite design

Nidhi  KM; Kumari Uma; Jaya  Sing; Amarjeet    Singh

doi:10.37022/jiaps.v7i1.275

KM Nidhi Department of Pharmaceutics, R V Northland Institute, Dadri, Greater Noida, U.P
Uma Kumari Department of Pharmaceutics, R V Northland Institute, Dadri, Greater Noida, U.P
Jaya Sing Assistant Professor, Innovative College of Pharmacy, Greater Noida
Amarjeet Singh Innovative college of pharmacyDr. A.P.J. Abdul Kalam Technical University

DOI https://doi.org/10.37022/jiaps.v7i1.275

Abstract

The work plans to build up a Gastro retentive floating drug delivery system of Model drug using central composite design. The model drug is a drug which is used in the treatment of antiulcer. Extended-release tablets of model drug provide constant plasma concentration with a less frequent administration and also reduce the side effects to some extent. This could extend its safe administration and improve patient compliance. The present study aims to develop floating tablets of model drug using HPMC K4M, Carbopol 934 and an effervescent agent which can float on gastrointestinal fluid for sustained release and evaluate the model drug tablets in-vitro for their TFT, FLT, and drug release pattern. Gastro retentive drug delivery system (GRDDS) refers to systems in which the drug retained in the stomach for a prolonged period that improves the bioavailability of drug substances. Any delivery system aims to deliver a therapeutic amount of drug to the specific site in the body to obtain rapid and then maintain a requisite amount of drug. The formulated tablets evaluated for both pre-compression and post compression parameters including weight variation, hardness, friability, in vitro drug release and different pharmacokinetic plots. Final formulation was agreeable when assessed for all assessment parameters.

Keywords: GRDDS, Absorption, Bioavailability, Gastric Emptying rate, Gastrointestinal transit time

Downloads

Download data is not yet available.

References

1. Sharma D and Sharma A. Gastro retentive drug delivery systems: A mini review. Asian Pacific Journal of Health Sciences, 2014; 1(2): 80-89.
2. Sandhan S., Singh R and Kalra S. Gastro retentive drug delivery system- A review. African Journal of Pharmacy and Pharmacology, 2015; 9(12): 405-417.
3. Chowdary, K. P. R., Chowdary, K. L. C. (2014).Recent Research Floating drug delivery systems- A review. Journal of Global Trends in Pharmaceutical Sciences, 2014; 5(1): 1361-1373.
4. www.rxlist.com (2015).
5. Jain, N. K. Pharmaceutical Product Development. New Delhi: CBS Publications & Distributors, first edition, 2006; 168-172.
6. Elmowafy, E. M., Awad, G. A. S., Mansour, S and El-Shamy, A. E. A.Release Mechanisms behind Polysaccharides-Based Model drug Controlled Release Matrix Tablets. American Association of Pharmaceutical Scientists Pharmaceutical Science Technology, 2008.2(4), 1230-1239.
7. Chaudhary A, Garud N, Garud A. Formulation and in-vitro characterization of floating drug delivery system of Nateglin¬ide. Am J PharmTech Res. 2013; 3(2): 477-486
8. Senthil A, Raja BD, Sureshkumar P, Thakkar HR, Sivakumar T. Chitosan Loaded Mucoadhesive Microspheres Of Glipizide For Treatment Of Type 2 Diabetes Mellitus In Vitro And In Vivo Evaluation: Research Article. Scholars Research Library. 2011; (3):366-379.
9. Sarfaraz Md, Venubabu.P, Doddayya Hiremath and Prakash SG. Mucoadhesive Dosage Form of Glibenclamide. Design And Characterisation: Research Article. Ijpbs. Apr-Jun 2012; (2):162-172.
10. VN Deshmukh, JK.Jadhav , DM sakarkar. Formulation and in vitro evaluation of theophylline anhydrous bioadhesive tablets;Asian journal of pharmaceutics; 2009, 3, 54-58.
11. “United States Pharmacopoeia”, xxiv NF 19, Rockville: United States Pharmacopoeia Convention; 2000.2388-9.
12. Gaba, P., Singh, S. and Gaba, M. (2011) Galactomannan Gum Coated Mucoadhesive Microspheres of Glipizide for Treatment of Type 2 Diabetes Mellitus: In Vitro and in Vivo Evaluation. Saudi Pharmaceutical Journal, 19, 143-152. http://dx.doi.org/10.1016/j.jsps.2011.02.001.
13. K shirsagar SJ, Wadekar SB, Bhalekar MR, Ughade PB, Madgulkar AR. Gastroretentive Drug Delivery System of Hydrochlorothiazide: Formulation, Optimization and In Vivo Evaluation. Asian Journal of Pharmaceutical Sciences, 2011; 6(3-4): 166-174).
14. Liu LS, Liu SQ, Ng SY, Froix M, Heller J. Controlled release of interleukin 2 for tumour immunotherapy using alginate/chitosan porous microspheres. J Control Release. 43, 1997, 65-74.
15. Deasy PB .Microencapsulation and related drug processes. New York, NY: Marcel Dekker, 1984.s